Skip to main content

Table 1 Clinical information of included patients

From: RFX2 downregulates RASSF1 expression and YAP phosphorylation through Hippo signaling to promote immune escape in lung adenocarcinoma

Clinical features

Patient number (n = 36)

Age

  ≤ 60 years

11

  > 60 years

25

Sex

 Female

16

 Male

20

Metastasis stage

 M0

29

 M1

7

TNM stage

 Stage I

7

 Stage II

9

 Stage III

13

 Stage IV

7

N stage

 N0

12

 N1

16

 N2

5

 N3

3

Back to article page

Cell Division

ISSN: 1747-1028

Contact us